Carmignac Gestion lowered its position in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 5.9% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 201,413 shares of the company's stock after selling 12,521 shares during the quarter. Carmignac Gestion's holdings in Procter & Gamble were worth $34,260,000 as of its most recent SEC filing.
Other large investors have also made changes to their positions in the company. Northern Trust Corp grew its position in Procter & Gamble by 0.8% in the first quarter. Northern Trust Corp now owns 29,644,000 shares of the company's stock worth $5,051,930,000 after acquiring an additional 248,792 shares in the last quarter. Goldman Sachs Group Inc. boosted its holdings in shares of Procter & Gamble by 3.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company's stock worth $2,966,252,000 after buying an additional 583,629 shares during the period. Charles Schwab Investment Management Inc. boosted its holdings in shares of Procter & Gamble by 1.2% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 17,090,898 shares of the company's stock worth $2,911,989,000 after buying an additional 208,991 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Procter & Gamble by 15.8% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 16,274,563 shares of the company's stock worth $2,728,430,000 after buying an additional 2,224,912 shares during the period. Finally, Invesco Ltd. boosted its holdings in shares of Procter & Gamble by 19.8% during the 1st quarter. Invesco Ltd. now owns 13,493,604 shares of the company's stock worth $2,299,580,000 after buying an additional 2,228,151 shares during the period. Institutional investors and hedge funds own 65.77% of the company's stock.
Procter & Gamble Price Performance
NYSE PG opened at $155.68 on Tuesday. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49. Procter & Gamble Company has a 12-month low of $149.91 and a 12-month high of $180.43. The company has a market capitalization of $364.66 billion, a PE ratio of 23.91, a price-to-earnings-growth ratio of 4.07 and a beta of 0.37. The firm's 50 day moving average is $157.05 and its 200-day moving average is $163.17.
Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, topping analysts' consensus estimates of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The firm had revenue of $20.89 billion during the quarter, compared to analysts' expectations of $20.79 billion. During the same period in the previous year, the business posted $1.40 earnings per share. The company's revenue for the quarter was up 1.7% compared to the same quarter last year. Equities research analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were paid a dividend of $1.0568 per share. The ex-dividend date of this dividend was Friday, July 18th. This represents a $4.23 annualized dividend and a yield of 2.7%. Procter & Gamble's payout ratio is presently 64.98%.
Wall Street Analyst Weigh In
Several research firms recently issued reports on PG. BNP Paribas reissued an "outperform" rating and issued a $177.00 price target on shares of Procter & Gamble in a research report on Friday. Erste Group Bank lowered shares of Procter & Gamble from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. Bank of America dropped their price target on shares of Procter & Gamble from $190.00 to $180.00 and set a "buy" rating for the company in a research report on Friday, April 25th. Truist Financial dropped their target price on shares of Procter & Gamble from $185.00 to $180.00 and set a "buy" rating for the company in a research report on Friday, April 25th. Finally, Redburn Atlantic cut shares of Procter & Gamble from a "buy" rating to a "neutral" rating and set a $161.00 target price for the company. in a research report on Thursday, May 1st. Seven investment analysts have rated the stock with a hold rating, eleven have issued a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, Procter & Gamble presently has a consensus rating of "Moderate Buy" and an average price target of $175.94.
Read Our Latest Research Report on PG
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.